A recent news article reported that "Cases of [Alzheimer's-like]
dementia explode globally" (1). Almost simultaneously, the Journal of
Inorganic Biochemistry published three articles implicating an
ingredient present in many vaccines, aluminum hydroxide. First, Maryline Couette and colleagues published "Long-term persistence of
vaccine-derived aluminum hydroxide is associated with chronic cognitive
dysfunction" (2).
Concurrently, Shaw and Petrik reported that "Aluminum hydroxide
injections lead to motor deficits and motor neuron degeneration". And
despite the presumed sanctity of vaccines and vaccinations, the
researchers dared conclude: "The demonstrated neurotoxicity of aluminum
hydroxide and its relative
ubiquity as an adjuvant suggest that greater scrutiny by the scientific
community is warranted." (3)
Aluminum hydroxide and other aluminum compounds are a component of
various medications (4-5) and vaccines (eg, 6-10), wherein aluminum
compounds serve as an adjuvant to hyperstimulate immunity (eg, 11).
Importantly, just as aluminum hydroxide is associated with cognitive
decline and with motor neuron pathologies, and aluminum compounds are
present in many vaccines, aluminum has again been found in Alzheimer's
plaques in humans (12).
Dare we ask, Who among us wants to be injected with a substance
associated with cognitive decline, motor neuron disease, and
Alzheimer's?
We know who among us wants to inject aluminum compounds along with thimerosal
(eg, 13-14), and squalene (eg, 15-18) under the guise of protecting our
health. But as numbers of people with dementia, rheumatoid diseases,
and autism continue to increase, perhaps time has come to desanctify
vaccinationism, vaccinology, vaccinologists and their marketing
representatives acting within the FDA and CDC.
Using vaccine ingredients to induce pathologies is an unwelcome burden
on affected individuals and their families.
References:
1.
Cases of dementia explode globally
More than 35 million live with the incurable ailment, which is expected
to double every 20 years worldwide.
By Lauran Neergaard
The Associated Press, 09/21/2009
http://www.denverpost.com/ci_13383636
2.
Long-term persistence of
vaccine-derived aluminum hydroxide is associated with chronic cognitive
dysfunction
Maryline Couette et al.
Journal of Inorganic Biochemistry (2009) in press
Macrophagic myofasciitis (MMF) is an emerging condition, characterized
by specific muscle lesions assessing long-term persistence of aluminum
hydroxide within macrophages at the site of previous immunization.
Affected patients mainly complain of arthromyalgias, chronic fatigue,
and cognitive difficulties. We designed a comprehensive battery of
neuropsychological tests to prospectively delineate MMF-associated
cognitive dysfunction (MACD). Compared to control patients with
arthritis and chronic pain, MMF patients had pronounced and specific
cognitive impairment. MACD mainly affected (i) both visual and verbal
memory; (ii) executive functions, including attention, working memory,
and planning; and (iii) left ear extinction at dichotic listening test.
Cognitive deficits did not correlate with pain, fatigue, depression, or
disease duration. Pathophysiological mechanisms underlying MACD remain
to be determined. In conclusion, long-term persistence of
vaccine-derived aluminum hydroxide within the body assessed by MMF is
associated with cognitive dysfunction, not solely due to chronic pain,
fatigue and depression.
3.
Aluminum hydroxide injections lead to
motor deficits and motor neuron degeneration
Christopher A. Shaw; Michael S. Petrik.
Journal of Inorganic Biochemistry (2009) in press
Gulf War Syndrome is a multi-system disorder afflicting many veterans
of Western armies in the 1990–1991 Gulf War. A number of those
afflicted may show neurological deficits including various cognitive
dysfunctions and motor neuron disease, the latter expression virtually
indistinguishable from classical amyotrophic lateral sclerosis (ALS)
except for the age of onset. This ALS ‘‘cluster” represents the second
such ALS cluster described in the literature to date. Possible causes
of GWS include several of the adjuvants in the anthrax vaccine and
others. The most likely culprit appears to be aluminum hydroxide. In an
initial series of experiments, we examined the potential toxicity of
aluminum hydroxide in male, outbred CD-1 mice injected subcutaneously
in two equivalent-to-human doses. After sacrifice, spinal cord and
motor cortex samples were examined by immunohistochemistry.
Aluminum-treated mice showed significantly increased apoptosis of motor
neurons and increases in reactive astrocytes and microglial
proliferation within the spinal cord and cortex. Morin stain detected
the presence of aluminum in the cytoplasm of motor neurons with some
neurons also testing positive for the presence of hyper-phosphorylated
tau protein, a pathological hallmark of various neurological diseases,
including Alzheimer’s disease and frontotemporal dementia. A second
series of experiments was conducted on mice injected with six doses of
aluminum hydroxide. Behavioural analyses in these mice revealed
significant impairments in a number of motor functions as well as
diminished spatial memory capacity. The demonstrated neurotoxicity of
aluminum hydroxide and its relative ubiquity as an adjuvant suggest
that greater scrutiny by the scientific community is warranted.
4.
Aluminum hydroxide
http://www.drugs.com/mtm/aluminum-hydroxide.html
5.
Aluminum hydroxide
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a699048.html
6.
Vaccine Ingredients...
http://www.rense.com/general59/vvac.htm
7.
Aluminum Hydroxide in Vaccines
http://www.associatedcontent.com/article/887707/aluminum_hydroxide_in_vaccines.html?cat=5
8.
Aluminum-hydroxide in vaccines causes
serious health problems
By Tenna Merchant
http://www.proliberty.com/observer/20071206.htm
9.
Aluminum: Vaccine Education Center
http://www.chop.edu/consumer/jsp/division/generic.jsp?id=88655
10.
Is Aluminum the New Thimerosal?
By Robert W. Sears
Mothering Magazine; Issue 146, January/February 2008
http://www.whale.to/vaccine/sears.html
11.
The Common Vaccine Adjuvant Aluminum
Hydroxide
Up-Regulates Accessory Properties of Human Monocytes via an
Interleukin-4-Dependent Mechanism
Marina Ulanova et al.
Infect Immun. 2001 February; 69(2): 1151–1159.
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=97997&blobtype=pdf
12.
Demonstration of aluminum in amyloid
fibers in the cores of senile plaques in the brains of patients with
Alzheimer’s disease
Sakae Yumoto et al.
Journal of Inorganic Biochemistry (2009) in press
Aluminum (Al) exposure has been reported to be a risk factor for
Alzheimer’s disease (senile dementia of Alzheimer type), although the
role of Al in the etiology of Alzheimer’s disease remains
controversial. We examined the presence of Al in the Alzheimer’s brain
using energy-dispersive X-ray spectroscopy combined with transmission
electron microscopy (TEM-EDX). TEM-EDX analysis allows simultaneous
imaging of subcellular structures with high spatial resolution and
analysis of small quantities of elements contained in the same
subcellular structures. We identified senile plaques by observation
using TEM and detected Al in amyloid fibers in the cores of senile
plaques located in the hippocampus and the temporal lobe by EDX.
Phosphorus and calcium were also present in the amyloid fibers. No Al
could be detected in the extracellular space in senile plaques or in
the cytoplasm of nerve cells. In this study, we demonstrated
colocalization of Al and beta-amyloid (Abeta) peptides in amyloid
fibers in the cores of senile plaques. The results support the
following possibilities in the brains of patients with Alzheimer’s
disease: Al could be involved in the aggregation of Abeta peptides to
form toxic fibrils; Al might induce Abeta peptides into the beta-sheet
structure; and Al might facilitate iron-mediated oxidative reactions,
which cause severe damage to brain tissues.
13.
Hepatitis B triple series vaccine and
developmental disability in US
children aged 1-9 years
Gallagher C, Goodman M. Toxicol Environ Chem 2008 90(5):997-1008.
{free online}
http://fourteenstudies.org/pdf/hep_b.pdf
"The odds of receiving EIS were approximately nine times as great for
vaccinated boys... as for unvaccinated boys..., after adjustment for
confounders.
14.
Hepatitis B vaccination of male
neonates and autism
[conference abstract as published]
CM Gallagher, MS Goodman, Graduate Program in Public
Health, Stony Brook University Medical Center, Stony Brook, NY
Annals of Epidemiology, p659
Vol. 19, No. 9 Abstracts (ACE) September 2009: 651–680
[triple the rate of autism among boys vaccinated with thimerosal versus
boys not so vaccinated]
15.
Vaccine A: The Covert Government
Experiment That's Killing Our Soldiers--And Why GI's Are Only The First
Victims
Gary Matsumoto, 2004.
http://www.amazon.com/Vaccine-Government-Experiment-Killing-Soldiers/dp/046504400X
16.
Squalene & Gulf War illnesses (GWI)
http://www.rense.com/general87/mill.htm
17.
Part 1: H1N1... vaccine and human
experimentation
http://tinyurl.com/m62nyd
18.
Part II: Squalene laced H1N1
vaccination
http://tinyurl.com/orf6de